Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.4M
-
Number of holders
-
144
-
Total 13F shares, excl. options
-
13.9M
-
Shares change
-
+4.33M
-
Total reported value, excl. options
-
$598M
-
Value change
-
+$188M
-
Put/Call ratio
-
0
-
Number of buys
-
96
-
Number of sells
-
-33
-
Price
-
$43.00
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q2 2018
154 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q2 2018.
Medpace Holdings, Inc. - Common Stock (MEDP) has 144 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.9M shares
of 28.4M outstanding shares and own 48.96% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.77M shares), BlackRock Inc. (1.61M shares), ACADIAN ASSET MANAGEMENT LLC (1.28M shares), Laurion Capital Management LP (680K shares), AMERIPRISE FINANCIAL INC (676K shares), BERNZOTT CAPITAL ADVISORS (487K shares), RENAISSANCE TECHNOLOGIES LLC (339K shares), DIMENSIONAL FUND ADVISORS LP (323K shares), TWO SIGMA INVESTMENTS, LP (319K shares), and STATE STREET CORP (303K shares).
This table shows the top 144 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.